| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.43B | 5.24B | 4.80B | 6.46B | 7.63B | 7.21B |
| Gross Profit | 1.39B | 1.46B | 1.35B | 1.29B | 2.20B | 2.56B |
| EBITDA | 1.71B | 1.78B | 1.62B | 2.25B | 3.28B | 3.55B |
| Net Income | -200.40M | -28.00M | 2.00M | -954.00M | 1.03B | 832.00M |
Balance Sheet | ||||||
| Total Assets | 25.01B | 25.24B | 24.11B | 23.76B | 25.08B | 25.27B |
| Cash, Cash Equivalents and Short-Term Investments | 770.00M | 716.00M | 843.00M | 1.16B | 1.69B | 1.86B |
| Total Debt | 6.05B | 5.91B | 6.37B | 7.58B | 7.38B | 7.91B |
| Total Liabilities | 13.62B | 13.70B | 12.21B | 12.98B | 12.84B | 13.78B |
| Stockholders Equity | 11.07B | 11.16B | 11.47B | 10.25B | 10.90B | 10.02B |
Cash Flow | ||||||
| Free Cash Flow | 1.05B | 462.97M | 365.00M | 127.00M | 1.17B | 1.89B |
| Operating Cash Flow | 2.12B | 1.62B | 1.65B | 1.43B | 2.33B | 2.88B |
| Investing Cash Flow | -1.13B | -1.16B | -1.29B | -1.38B | -1.17B | -1.10B |
| Financing Cash Flow | -825.71M | -621.70M | -501.00M | -776.00M | -1.33B | -841.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | C$13.35B | 11.10 | 20.70% | 0.07% | 14.46% | 316.60% | |
78 Outperform | C$32.43B | 18.96 | 23.11% | 0.68% | 18.62% | ― | |
72 Outperform | C$3.86B | 6.49 | 31.19% | ― | 87.54% | 1269.40% | |
65 Neutral | C$9.70B | 14.29 | 12.69% | ― | 37.06% | 421.94% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | C$3.32B | 48.59 | 2.27% | ― | 27.92% | ― | |
57 Neutral | C$29.66B | -25.38 | -1.78% | ― | 9.31% | -245.11% |